Covered recipient · General Payments record
JAY ROSENBERG
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$129,071.88
- Reported across 646 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,181.58 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| EMD Serono, Inc. | $385.68 | 9 |
| AXOGEN | $192.78 | 1 |
| Medtronic, Inc. | $164.22 | 1 |
| Amgen Inc. | $156.90 | 3 |
| TG THERAPEUTICS, INC. | $124.99 | 1 |
| Alexion Pharmaceuticals, Inc. | $82.55 | 1 |
| Genentech, Inc. | $74.46 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | $82.55 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093943966 | CMS |
| Amgen Inc. | $29.58 | 02/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111692322 | CMS |
| Amgen Inc. | $50.88 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111692324 | CMS |
| Amgen Inc. | $76.44 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111692326 | CMS |
| AXOGEN | $192.78 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143641949 | CMS |
| EMD Serono, Inc. | $23.82 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120237382 | CMS |
| EMD Serono, Inc. | $147.79 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120248895 | CMS |
| EMD Serono, Inc. | $22.50 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120245367 | CMS |
| EMD Serono, Inc. | $11.39 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120248821 | CMS |
| EMD Serono, Inc. | $9.85 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120250879 | CMS |
| EMD Serono, Inc. | $19.53 | 09/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120260914 | CMS |
| EMD Serono, Inc. | $19.53 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120267508 | CMS |
| EMD Serono, Inc. | $9.19 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120267522 | CMS |
| EMD Serono, Inc. | $122.08 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120278272 | CMS |
| Genentech, Inc. | $39.47 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133028355 | CMS |
| Genentech, Inc. | $34.99 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133028351 | CMS |
| Medtronic, Inc. | $164.22 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119399590 | CMS |
| TG Therapeutics, Inc. | $124.99 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136876088 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.